Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans-Reference-Cited by-同舟云学术

Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans

Published:2020-03-24 Issue:4 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Delma Fatima Zohra¹,Al-Hatmi Abdullah M. S.²³⁴,Buil Jochem B.¹³,van der Lee Hein¹³,Tehupeiory-Kooreman Marlou¹³,de Hoog G. Sybren²³,Meletiadis Joseph⁵⁶,Verweij Paul E.¹³

Affiliation:

1. Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands

2. Foundation Atlas of Clinical Fungi, Hilversum, The Netherlands

3. Centre of Expertise in Mycology of Radboudumc/CWZ, Nijmegen, The Netherlands

4. Ministry of Health, Directorate General of Health Services, Ibri, Oman

5. Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

6. Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands

Abstract

We compared MIC test strip (MTS) and Sensititre YeastOne (SYO) methods with EUCAST and CLSI methods for amphotericin B, 5-fluocytosine, fluconazole, voriconazole, and isavuconazole against 106 Cryptococcus neoformans isolates. The overall essential agreement between the EUCAST and CLSI methods was >72% and >94% at ±1 and ±2 dilutions, respectively. The essential agreements between SYO and EUCAST/CLSI for amphotericin B, 5-flucytosine, fluconazole, and voriconazole were >89/>93% and between MTS and EUCAST/CLSI were >57/>75%.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.02261-19

Reference24 articles.

1. Cryptococcal meningitis: epidemiology and therapeutic options

2. Cryptococcosis

3. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

4. Cryptococcus–Epithelial Interactions

5. The war on cryptococcosis: A Review of the antifungal arsenal

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic mutations in Cryptococcus neoformans pyrimidine salvage pathway enzymes contribute to reduced susceptibility against 5-fluorocytosine;npj Antimicrobials and Resistance;2024-09-10

2. The performance and costs of XTT, resazurin, MTS and luciferin as viability dyes in in vitro susceptibility testing of Madurella mycetomatis;Transactions of The Royal Society of Tropical Medicine and Hygiene;2024-05-09

3. Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011–2021;Mycoses;2024-01

4. Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffei;Medical Mycology;2023-11

5. Rapid automated antifungal susceptibility testing system for yeasts based on growth characteristics;Frontiers in Cellular and Infection Microbiology;2023-05-02